Molecular dynamics simulations of human rhinovirus and an antiviral compound.
暂无分享,去创建一个
B. Brooks | B. Speelman | C. Post | B R Brooks | C B Post | B Speelman
[1] M. Rossmann,et al. Cations in human rhinoviruses. , 1997, Virology.
[2] Alasdair C. Steven,et al. Molecular Tectonic Model of Virus Structural Transitions: the Putative Cell Entry States of Poliovirus , 2000, Journal of Virology.
[3] A. Treasurywala,et al. Conformational change in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors , 1989, Journal of virology.
[4] R E Cachau,et al. Ion channels in icosahedral virus: a comparative analysis of the structures and binding sites at their fivefold axes. , 1992, Biophysical journal.
[5] M. Chow,et al. Stabilization of poliovirus by capsid-binding antiviral drugs is due to entropic effects. , 2000, Journal of molecular biology.
[6] J C Sacchettini,et al. Escherichia coli-derived rat intestinal fatty acid binding protein with bound myristate at 1.5 A resolution and I-FABPArg106-->Gln with bound oleate at 1.74 A resolution. , 1994, The Journal of biological chemistry.
[7] Bernard R. Brooks,et al. New spherical‐cutoff methods for long‐range forces in macromolecular simulation , 1994, J. Comput. Chem..
[8] T. Smith,et al. Picornaviruses: epitopes, canyons, and pockets. , 1999, Advances in virus research.
[9] G. Siuzdak,et al. Antiviral agent blocks breathing of the common cold virus. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[10] A method for modeling icosahedral virions: Rotational symmetry boundary conditions , 1991 .
[11] K Schulten,et al. VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.
[12] N. Vaidehi,et al. The pentamer channel stiffening model for drug action on human rhinovirus HRV-1A. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[13] G Vriend,et al. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. , 1986, Science.
[14] Terry P. Lybrand,et al. Computer simulation study of the binding of an antiviral agent to a sensitive and a resistant human rhinovirus , 1989, J. Comput. Aided Mol. Des..
[15] M. Rossmann,et al. Structural studies on human rhinovirus 14 drug-resistant compensation mutants. , 1995, Journal of molecular biology.
[16] E A Merritt,et al. Raster3D: photorealistic molecular graphics. , 1997, Methods in enzymology.
[17] P. Rossky,et al. Influence of an antiviral compound on the temperature dependence of viral protein flexibility and packing: a molecular dynamics study. , 1998, Journal of molecular biology.
[18] Molecular dynamics simulation of a rhinovirus capsid under rotational symmetry boundary conditions , 1996 .
[19] D. Filman,et al. Three-dimensional structure of poliovirus at 2.9 A resolution. , 1985, Science.
[20] M. Otto,et al. Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug , 1986, Antimicrobial Agents and Chemotherapy.
[21] S. Swaminathan,et al. Molecular dynamics of HIV‐1 protease , 1992, Proteins.
[22] Daniel C. Pevear,et al. Activity of Pleconaril against Enteroviruses , 1999, Antimicrobial Agents and Chemotherapy.
[23] M G Rossmann,et al. Structural analysis of a series of antiviral agents complexed with human rhinovirus 14. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[24] M. Rossmann,et al. Human rhinovirus 14 complexed with fragments of active antiviral compounds. , 1994, Virology.
[25] John E. Johnson,et al. Structure of a human common cold virus and functional relationship to other picornaviruses , 1985, Nature.
[26] D. Stuart,et al. The crystal structure of coxsackievirus A9: new insights into the uncoating mechanisms of enteroviruses. , 1999, Structure.
[27] J. Hogle,et al. Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding , 1990, Journal of virology.
[28] M. Chow,et al. Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature , 1994, Journal of virology.
[29] D. Beglov,et al. Finite representation of an infinite bulk system: Solvent boundary potential for computer simulations , 1994 .
[30] M. Karplus,et al. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .
[31] B. Rombaut,et al. A comparison of WIN 51711 and R 78206 as stabilizers of poliovirus virions and procapsids. , 1991, The Journal of general virology.
[32] C. Post,et al. A novel basis of capsid stabilization by antiviral compounds. , 1995, Journal of molecular biology.
[33] M G Rossmann,et al. Structure of a human rhinovirus complexed with its receptor molecule. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[34] J. Sacchettini,et al. Structural studies on human muscle fatty acid binding protein at 1.4 A resolution: binding interactions with three C18 fatty acids. , 1994, Structure.
[35] B. Speelman,et al. Theoretical studies of viral capsid proteins. , 2000, Current opinion in structural biology.
[36] G. Schulz,et al. Adenylate kinase motions during catalysis: an energetic counterweight balancing substrate binding. , 1996, Structure.
[37] M G Rossmann,et al. The structure of coxsackievirus B3 at 3.5 A resolution. , 1995, Structure.
[38] W. Chiu,et al. Structural biology of viruses , 1997 .
[39] A. Mosser,et al. WIN 51711-dependent mutants of poliovirus type 3: evidence that virions decay after release from cells unless drug is present , 1993, Journal of virology.
[40] M. Karplus,et al. Molecular dynamics simulations of native and substrate-bound lysozyme. A study of the average structures and atomic fluctuations. , 1986, Journal of molecular biology.
[41] M. Rossmann,et al. The structure of coxsackievirus B3. , 1997, Current topics in microbiology and immunology.
[42] C. Post,et al. Molecular dynamics investigation of the effect of an antiviral compound on human rhinovirus , 2008, Protein science : a publication of the Protein Society.